Note 9 - Share Capital (Details Textual) $ / shares in Units, $ / shares in Units, $ in Thousands, $ in Millions |
|
|
|
|
12 Months Ended |
|
|
|
Nov. 29, 2021
USD ($)
$ / shares
shares
|
Sep. 08, 2020
USD ($)
$ / shares
shares
|
Apr. 30, 2020
USD ($)
|
Apr. 30, 2020
CAD ($)
$ / shares
shares
|
Jun. 15, 2017
shares
|
Dec. 31, 2021
USD ($)
$ / shares
shares
|
Dec. 31, 2021
USD ($)
$ / shares
shares
|
Dec. 31, 2020
USD ($)
$ / shares
shares
|
Dec. 31, 2020
USD ($)
$ / shares
shares
|
Jul. 18, 2020 |
Dec. 31, 2019 |
| Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Number of shares outstanding at end of period (in shares) |
|
|
|
|
|
97,809,441
|
97,809,441
|
94,813,122
|
94,813,122
|
|
|
| Total number of shares issued (in shares) |
2,691,000
|
3,092,783
|
|
4,528,302
|
|
|
|
|
|
|
|
| Shares Issued, Price Per Share (in dollars per share) | $ / shares |
$ 17.15
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from issue of ordinary shares |
$ 46,151
|
$ 48,625
|
$ 43,134
|
$ 60
|
|
|
|
|
|
|
|
| Shares issued, share issue costs, commission | $ |
2,301
|
|
|
|
|
|
|
|
|
|
|
| Shares issued, share issue costs, legal and filing | $ |
608
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from issue of ordinary shares, net of share issue costs | $ |
$ 43,242
|
|
|
|
|
$ 43,242
|
|
$ 89,164
|
|
|
|
| Issue of equity, price per share (in CAD per share) | $ / shares |
|
|
|
$ 13.25
|
|
|
|
|
|
|
|
| Issued capital | $ |
|
$ 50,000
|
|
|
|
$ 543,927
|
$ 543,927
|
$ 496,604
|
$ 496,604
|
|
|
| Issue of equity, average price per share (in dollars per share) | $ / shares |
|
$ 16.17
|
|
|
|
|
|
|
|
|
|
| Number of share options exercised for cash in share-based payment arrangement |
|
|
|
|
|
75,066
|
|
418,294
|
|
|
|
| Proceeds from exercise of options | $ |
|
|
|
|
|
$ 985
|
|
$ 3,337
|
|
|
|
| Number of share options exercised in share-based payment arrangement, cashless |
|
|
|
|
|
54,274
|
|
365,483
|
|
|
|
| Shares issued in lieu of exercise of stock options (in shares) |
|
|
|
|
|
25,089
|
|
139,273
|
|
|
|
| Number of share options cancelled during the period (in shares) |
|
|
|
|
|
29,185
|
|
226,210
|
|
|
|
| Shares issued in lieu of payment (in shares) |
|
|
|
|
|
5,223
|
|
8,241
|
|
|
|
| Mineral property option payment settled by share issuance | $ |
|
|
|
|
|
$ 100
|
|
$ 100
|
|
|
|
| Stock options issuance limitations, maximum percentage of allowed issuable common shares |
|
|
|
|
5.00%
|
|
|
|
|
|
|
| Option life, share options granted |
|
|
|
|
|
3
|
|
3
|
|
|
|
| Number of share options outstanding in share-based payment arrangement at end of period |
|
|
|
|
|
988,727
|
988,727
|
1,018,067
|
1,018,067
|
|
1,229,341
|
| Number of share options granted in share-based payment arrangement |
|
|
|
|
|
100,000
|
|
572,503
|
|
|
|
| Weighted average fair value at measurement date, share options granted | $ |
|
|
|
|
|
$ 686
|
$ 686
|
$ 2,546
|
$ 2,546
|
|
|
| Weighted average share price, share options granted (in dollars per share) | $ / shares |
|
|
|
|
|
$ 6.86
|
|
$ 4.45
|
|
|
|
| Options vesting, percent, tranche one |
|
|
|
|
|
0.33%
|
|
|
|
|
|
| Options vesting, period, tranche one (Month) |
|
|
|
|
|
12 months
|
|
|
|
|
|
| Options vesting, period, tranche two (Month) |
|
|
|
|
|
24 months
|
|
|
|
|
|
| Options vesting, period, tranche three (Month) |
|
|
|
|
|
36 months
|
|
|
|
|
|
| Number of share options exercised in share-based payment arrangement |
|
|
|
|
|
129,340
|
|
783,777
|
|
|
|
| Weighted average market share price of share options exercised In share based payment arrangement (in CAD per share) | $ / shares |
|
|
|
|
|
|
$ 22.35
|
|
$ 21.79
|
|
|
| Expense from share-based payment transactions with employees and consultants | $ |
|
|
|
|
|
$ 1,564
|
|
$ 1,069
|
|
|
|
| Expense arising from exploration for and evaluation of mineral resources | $ |
|
|
|
|
|
49
|
|
15
|
|
|
|
| Restricted and performance Units issuance limitations, maximum percentage of allowed issuable common shares |
|
|
|
|
1.50%
|
|
|
|
|
|
|
| Life of restricted share units and performance share units (Year) |
|
|
|
|
5 years
|
|
|
|
|
|
|
| Number of common shares issuable from a restricted share unit (in shares) |
|
|
|
|
1
|
|
|
|
|
|
|
| Expense from share-based payment transactions with employees | $ |
|
|
|
|
|
$ 4,256
|
|
$ 3,122
|
|
|
|
| Deferred Units issuance limitations, maximum percentage of allowed issuable common shares |
|
|
|
|
|
|
|
|
|
1.00%
|
|
| Number of other equity instruments available for settlement in share-based payment arrangement (in shares) |
|
|
|
|
|
86,295
|
86,295
|
|
|
|
|
| Common shares issuable under share-based compensation arrangements (in shares) |
|
|
|
|
|
1,722,974
|
1,722,974
|
1,882,225
|
1,882,225
|
|
|
| Percentage of common shares issuable and common shares issued and outstanding |
|
|
|
|
|
1.76%
|
1.76%
|
1.99%
|
1.99%
|
|
|
| Number of share based awards available for grant (in shares) |
|
|
|
|
|
4,145,592
|
4,145,592
|
3,806,562
|
3,806,562
|
|
|
| Options vesting, percent, tranche two |
|
|
|
|
|
|
|
0.33%
|
|
|
|
| Options vesting, percent, tranche three |
|
|
|
|
|
|
|
0.33%
|
|
|
|
| Stock options inside of plan [member] |
|
|
|
|
|
|
|
|
|
|
|
| Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Number of share options outstanding in share-based payment arrangement at end of period |
|
|
|
|
|
988,727
|
988,727
|
|
|
|
|
| Restricted share units [member] |
|
|
|
|
|
|
|
|
|
|
|
| Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement |
|
|
|
|
|
31,620
|
|
3,334
|
|
|
|
| Number of other equity instruments granted in share-based payment arrangement |
|
|
|
|
|
10,000
|
|
39,063
|
|
|
|
| Weighted average remaining contractual life of other equity instruments granted in share-based payment arrangement (Year) |
|
|
|
|
|
5 years
|
|
|
|
|
|
| Weighted average exercise price of other equity instruments forfeited in share-based payment arrangement (in dollars per share) | $ / shares |
|
|
|
|
|
$ 18.44
|
|
$ 11.26
|
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement at end of period |
|
|
|
|
|
24,109
|
24,109
|
45,729
|
45,729
|
|
|
| Number of other equity instruments vested and convertible in share-based payment arrangement (in shares) |
|
|
|
|
|
10,776
|
10,776
|
0
|
0
|
|
|
| Performance share units [member] |
|
|
|
|
|
|
|
|
|
|
|
| Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement |
|
|
|
|
|
8,511
|
|
17,048
|
|
|
|
| Number of other equity instruments granted in share-based payment arrangement |
|
|
|
|
|
0
|
|
146,755
|
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement at end of period |
|
|
|
|
|
240,765
|
240,765
|
249,276
|
249,276
|
|
|
| Number of other equity instruments vested and convertible in share-based payment arrangement (in shares) |
|
|
|
|
|
6,346
|
6,346
|
14,857
|
14,857
|
|
|
| Number of other equity instruments outstanding with vesting conditions subject to a market share price performance factor (in shares) |
|
|
|
|
|
87,664
|
87,664
|
87,664
|
87,664
|
|
|
| Number of other equity instruments exercisable in share-based payment arrangement |
|
|
|
|
|
48,918
|
48,918
|
|
|
|
|
| Deferred share units [member] |
|
|
|
|
|
|
|
|
|
|
|
| Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement |
|
|
|
|
|
159,810
|
|
60,000
|
|
|
|
| Number of other equity instruments granted in share-based payment arrangement |
|
|
|
|
|
54,213
|
|
64,757
|
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement at end of period |
|
|
|
|
|
469,373
|
469,373
|
569,153
|
569,153
|
|
|
| Expense from share-based payment transactions with employees | $ |
|
|
|
|
|
$ 1,208
|
|
$ 867
|
|
|
|
| Number of instruments other equity instruments granted in lieu of director fees (in shares) |
|
|
|
|
|
5,818
|
|
10,482
|
|
|
|
| Number of common shares issued under the deferred share unit plan prior to termination date (in shares) |
|
|
|
|
|
0
|
0
|
|
|
|
|
| Stock option awards [member] |
|
|
|
|
|
|
|
|
|
|
|
| Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Option life, share options granted |
|
|
|
|
|
5
|
|
|
|
|
|
| Restricted share units and performance share units [member] |
|
|
|
|
|
|
|
|
|
|
|
| Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Expense from share-based payment transactions with employees | $ |
|
|
|
|
|
$ 1,533
|
|
$ 1,201
|
|
|
|
| Top of range [member] |
|
|
|
|
|
|
|
|
|
|
|
| Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Issue of equity, at-the-market equity program, shares authorized (in shares) |
|
50,000,000
|
|
|
|
|
|
|
|
|
|
| Option life, share options granted |
|
|
|
|
5
|
|
|
|
|
|
|
| Performance share unit payout, percentage |
|
|
|
|
|
200.00%
|
|
|
|
|
|
| Performance share unit payout, units (in shares) |
|
|
|
|
|
175,328
|
|
|
|
|
|
| Top of range [member] | Performance share units [member] |
|
|
|
|
|
|
|
|
|
|
|
| Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Performance share unit payout, percentage |
|
|
|
|
|
150.00%
|
|
|
|
|
|
| Performance share unit payout, units (in shares) |
|
|
|
|
|
73,377
|
|
|
|
|
|
| Bottom of range [member] |
|
|
|
|
|
|
|
|
|
|
|
| Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Performance share unit payout, percentage |
|
|
|
|
|
0.00%
|
|
|
|
|
|
| Performance share unit payout, units (in shares) |
|
|
|
|
|
0
|
|
|
|
|
|
| Bottom of range [member] | Performance share units [member] |
|
|
|
|
|
|
|
|
|
|
|
| Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Performance share unit payout, percentage |
|
|
|
|
|
50.00%
|
|
|
|
|
|
| Performance share unit payout, units (in shares) |
|
|
|
|
|
24,459
|
|
|
|
|
|